Engineers Gate Manager LP Tyme Technologies, Inc. Transaction History

Engineers Gate Manager LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$0.28 - $0.68 $5,919 - $14,376	-21,142 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.04 $12,685 - $21,987	21,142 New	21,142 $13,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.